MAR 22, 2017 2:18 PM PDT

Breast Implants Carry Risk For Rare Cancer, FDA Finds

WRITTEN BY: Xuan Pham

The Food and Drug Administration recently highlighted a link between breast implants and a rare cancer that’s claimed at least 9 lives.

The cancer is known as anaplastic large cell lymphoma (ALCL), and is considered a rare form of non-Hodgkin's lymphoma. In total, since February 1 of this year, 359 cases of such cancer have been reported, including 9 deaths.

Importantly, the FDA makes a clear distinction that the deaths were not caused by breast cancer. Rather, the malignant cells can be found in the scar tissues surrounding the breast implant.

"All of the information to date suggests that women with breast implants have a very low but increased risk of developing ALCL compared to women who do not have breast implants," wrote the FDA.

They also highlighted another interesting link concerning the type of breast implants that seemed to be more associated with cancer. Textured implants – those with a pebbly surface designed to minimize shifting post-surgery – seem to increase the risk of cancer development.

“When we take these out, you can hear a peeling sound,” said Dr. Alex Wong, a plastic surgeon and researcher at the University of Southern California’s Keck School of Medicine. “Whereas with a smooth implant, it’s like Jell-O. You can spin it around. It moves really easily.”

“We’re still trying to find out why the surface matters,” said Dr. Wong. It’s not hard to imagine, however, that cells can better attach and nest into textured surfaces versus smooth surfaces. The content of the implant – silicone or saline – does not seem to influence cancer development.

The FDA’s announcement marks a more conclusive update on this matter, which was raised back in 2011. However, at the time, researchers did not have enough evidence to suggest a possible link.

Fortunately, the cancer seems to be rare and not commonly fatal. The FDA suggests that removing the diseased tissue and implants is sufficient for most affected women, although some do require extended cancer treatments. Further, they note that women with implants who don’t show symptoms – lumps, pain, swelling of the breast area – are likely at low risk for the cancer.

Additional sources: CNN, The New York Times

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
MAY 24, 2021
Health & Medicine
How do healthcare insurance disruptions affect access and affordability to care?
MAY 24, 2021
How do healthcare insurance disruptions affect access and affordability to care?
Have you ever been in between health insurance coverage and pushed off receiving healthcare that you needed? According t ...
MAY 28, 2021
Cancer
Does your birth control increase your risk of breast cancer?
MAY 28, 2021
Does your birth control increase your risk of breast cancer?
A study published recently in EMBO Molecular Medicine considers the biological impacts of progestins from hormonal contr ...
JUN 10, 2021
Cell & Molecular Biology
Does Lithium Prevent Colon Cancer?
JUN 10, 2021
Does Lithium Prevent Colon Cancer?
Researchers found that a drug used in the treatment of mental illness can promote the fitness of healthy gut stem cells, ...
JUN 18, 2021
Cancer
Cancer cell lines are too dissimilar from human cancer cells
JUN 18, 2021
Cancer cell lines are too dissimilar from human cancer cells
A new study finds cultured cancer cells lack genetic similarity to humans. This is concerning because cancer cell lines ...
JUL 08, 2021
Genetics & Genomics
Is It Possible to Prevent Leukemia in Down Syndrome Patients?
JUL 08, 2021
Is It Possible to Prevent Leukemia in Down Syndrome Patients?
Children with Down syndrome have a significantly higher likelihood myeloid leukemia occurring in the first five years of ...
AUG 04, 2021
Health & Medicine
Cannabis Drug Sativex to Be Tested in Phase II Brain Tumor Trial
AUG 04, 2021
Cannabis Drug Sativex to Be Tested in Phase II Brain Tumor Trial
  A phase II trial is being planned to test the cannabis-derived drug Sativex, in patients with aggressive brain tu ...
Loading Comments...